[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
About the Journal
Editorial Board
Advisory Board
Aims & Scope
Journal News
Articles archive::
All Issues
Current Issue
Articles in press
For Authors::
Submission Instruction
For Reviewers::
Reviewers Section
Subscription::
Subscription Form
News& Events::
Journal News
Contact us::
Contact Information
Contact us
Site Facilities::
Site map
Search contents
Top 10 contents
Inform others
Ethics & Permissions::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Indexing
                        
..
:: Volume 18, Issue 4 (Winter 2021) ::
Sci J Iran Blood Transfus Organ 2021, 18(4): 233-240 Back to browse issues page
Assessment of the prevalence of non-alcoholic fatty liver disease in regular and non-regular blood and plasma donors
M.R. Sasani , M. Izadi
Keywords: Key words: Liver Diseases, Prevalence, Blood Donation
Full-Text [PDF 468 kb]   (819 Downloads)     |   Abstract (HTML)  (1140 Views)
Type of Study: Research | Subject: Blood transfusion medicine
Published: 2021/12/31
Full-Text:   (6296 Views)
    References:
 
  1. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis 2004; 24: 3-20.
  2. Harrison SA, Neuschwander-Tetri BA. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis 2004; 8(4): 861-79.
  3. Younossi Z, Diehl AM, Ong JP. Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology 2002; 35: 746-52.
  4. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for non alcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005; 42: 44-52.
  5. Byron D, Minuk GY. Clinical hepatology: profile of an urban, hospital-based practice. Hepatology 1996; 24(4): 813-5.
  6. Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E, et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011; 343: d6891. 
  7. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2007; 25(8): 883-9. 
  8. Lankarani KB, Ghaffarpasand F, Mahmoodi M, Lotfi M, Zamiri N, Heydari ST, et al. Non Alcoholic Fatty Liver Disease in Southern Iran: A Population Based Study. Hepat Mon 2013; 13(5): e9248.
  9. Musso G, Gambino R, Bo S, Uberti B, Biroli G, Pagano G, et al. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Diabetes Care 2008; 31(3): 562-8. 
  10. Mohammad Alizadeh AH, Hadizadeh M, Padashi M, Ranjbar M. Non-Alcoholic Fatty Liver Disease Frequency among Healthy Blood Donors in the West of Iran. Arch Hepat Res 2016; 2(1): 1-4.
  11. Pourshams A, Malekzadeh R, Monavvari A, Akbari MR, Mohamadkhani A, Yarahmadi S, et al. Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. J Gastroenterol Hepatol 2005; 20(2): 229-33.
  12. Lahsaee S, Ghazizade A, Yazdanpanah M, Enhesari A, Malekzadeh R. Assessment of NAFLD cases and its correlation to BMI and metabolic syndrome in healthy blood donors in Kerman. Gastroenterol Hepatol Bed Bench 2012; 5(4): 183-9.
  13. Lankarani KB, Ghaffarpasand F, Mahmoodi M, Lotfi M, Zamiri N, Heydari FT, et al. Non Alcoholic Fatty Liver Disease in Southern Iran: A Population Based Study. Hepat Mon 2013; 13(5): e9248.
  14. Duseja A, Najmy S, Sachdev S, Pal A, Sharma RR, Marwah N, Chawla Y. High prevalence of non-alcoholic fatty liver disease among healthy male blood donors of urban India. JGH Open 2019; 3(2): 133-9.
  15. Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 2005; 43: 508-14.
  16. Singh SP, Nayak S, Swain M, Rout N, Mallik RN, Agrawal O, et al. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Trop Gastroenterol 2004; 25(2): 76-9.
  17. Omagari K, Kadokawa Y, Masuda J. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics.J Gastroenterol Hepatol 2002; 17: 1098-105.
  18. Jamali R, Khonsari M, Merat S. Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol 2008; 14: 2867-71.
  19. Hashimoto E, Yatsuji S, Tobari M. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 2009; 44(Suppl. 19): 89-95.
  20. Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004; 164: 2169-75.
  21. Chen ZW, Chen LY, Dai HL, Chen JH, Fang LZ.
    Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease.J Zhejiang Univ Sci B 2008; 9: 616-22.
  22. Sorrentino P, Tarantino G, Conca P. Silent non-alcoholic fatty liver disease-a clinical-histological study. J Hepatol 2004; 41: 751-7.
  23. Piton A, Poynard T, Imbert-Bismut F. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group.Hepatology 1998; 27: 1213-9.
  24. Kariv R, Leshno M, Beth-Or A. Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study. Liver Int 2006; 26: 445-50.
  25. Kunde SS, Lazenby AJ, Clements RH, Abrams GA. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology 2005; 42: 650-6.
  26. Vernon G, Baranova A, Younossi Z. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34(3): 274-85.
  27. Duseja A, Das A, Das R, Dhiman RK, Chawla Y, Bhansali A, et al. The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West. Dig Dis Sci 2007; 52(9): 2368-74.
  28. Moghaddasifar I, Lankarani KB, Moosazadeh M, Afshari M, Ghaemi A, Aliramezany M, et al. Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran. Int J Organ Transplant Med 2016; 7(3): 149-60.
 

 
 
 
 
Sci J Iran Blood Transfus Organ 2021;18 (4): 233-240
Original Article
 
 
 
 
 


Assessment of the prevalence of non-alcoholic fatty liver
disease in regular and non-regular blood
and plasma donors
 
Sasani M.R.1, Izadi M.2,3
 
 
1Medical Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
3Shiraz Regional Educational Blood Transfusion Center, Shiraz, Iran
 
Abstract
Background and Objectives
Non-alcoholic liver disease (NAFLD) is a spectrum of diseases, ranging from non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH) which can lead to liver cirrhosis and hepatocellular carcinoma. Nonalchololic fatty liver  is the most prevalent hepatic disorder worldwide which can affect up to the one out of four adults. Little is known about the prevalence of nonalchololic fatty liver among regular donors of blood products. The current study shows the prevalence of nonalchololic fatty liver  in regular plasma and blood donors with a discontinuous donor population.
 
Materials and Methods
In this case-control study, we non-randomly enrolled 400 volunteers of blood donors who met the blood donation criteria after signing the written informed consent. All patients underwent hepatobiliary ultrasonography to evaluate fatty liver. LFT (Liver Function Test) and demographic criteria had been submitted in data base. All data were described by central dispersion indices and analyzed by Mann-Whitney U test and chi-square.
 
Results
No difference was seen regarding gender and mean age between groups (p-value of 0.441 and 0.635, respectively). According to univariate analysis there was no significant difference between the two groups regarding the prevalence of fatty liver (p= 0.264) or its staging (p= 0.9). In addition, OR and RR were 1.17 and 1.11, respectively; both not being significant (p= 0.461).
 
Conclusions 
The prevalence of NAFLD has no significant correlation with both regular blood donors and non-regular blood donors.
 
Key words: Liver Diseases, Prevalence, Blood Donation
 
 
 
 
Received:  7 Mar 2021
Accepted: 4 Sep 2021
 
 

Correspondence:Izadi M., Radiologist. Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine and Shiraz Blood Transfusion Center.
P.O.Box: 1153, Shiraz,  Iran. Tel: (+9871) 6273445; Fax: (+9871) 6264006
E-mail: ifatemeh241@gmail.com
Add your comments about this article
Your username or Email:

CAPTCHA

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sasani M, Izadi M. Assessment of the prevalence of non-alcoholic fatty liver disease in regular and non-regular blood and plasma donors. Sci J Iran Blood Transfus Organ 2021; 18 (4) :233-240
URL: http://bloodjournal.ir/article-1-1393-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 18, Issue 4 (Winter 2021) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.06 seconds with 39 queries by YEKTAWEB 4660